Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Fish and Richardson
Harvard Business School
Queensland Health
Chinese Patent Office
US Army
QuintilesIMS
Julphar
Merck

Generated: October 19, 2018

DrugPatentWatch Database Preview

R-pharm Us Llc Company Profile

« Back to Dashboard

What is the competitive landscape for R-PHARM US LLC, and what generic alternatives to R-PHARM US LLC drugs are available?

R-PHARM US LLC has one approved drug.

There are six US patents protecting R-PHARM US LLC drugs.

Summary for R-pharm Us Llc
US Patents:6
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for R-pharm Us Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;INTRAVENOUS 022065-001 Oct 16, 2007 RX Yes Yes 7,125,899*PED ➤ Sign Up Y ➤ Sign Up
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;INTRAVENOUS 022065-002 Oct 16, 2007 RX Yes Yes 7,125,899*PED ➤ Sign Up Y ➤ Sign Up
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;INTRAVENOUS 022065-001 Oct 16, 2007 RX Yes Yes RE41393*PED ➤ Sign Up Y ➤ Sign Up
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;INTRAVENOUS 022065-002 Oct 16, 2007 RX Yes Yes RE41911*PED ➤ Sign Up Y ➤ Sign Up
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;INTRAVENOUS 022065-001 Oct 16, 2007 RX Yes Yes 7,312,237*PED ➤ Sign Up Y ➤ Sign Up
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;INTRAVENOUS 022065-001 Oct 16, 2007 RX Yes Yes 7,022,330*PED ➤ Sign Up Y ➤ Sign Up
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;INTRAVENOUS 022065-002 Oct 16, 2007 RX Yes Yes 7,312,237*PED ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for R-pharm Us Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;INTRAVENOUS 022065-001 Oct 16, 2007 6,605,599 ➤ Sign Up
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;INTRAVENOUS 022065-002 Oct 16, 2007 6,605,599 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for R-PHARM US LLC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 15 mg/vial and 45 mg/vial, single-use vials ➤ Subscribe 2012-04-16

Supplementary Protection Certificates for R-pharm Us Llc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1019389/01 Switzerland ➤ Sign Up PRODUCT NAME: IXABEPILONE; REGISTRATION NUMBER/DATE: SWISSMEDIC 58880 27.02.2009
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Chubb
Accenture
Mallinckrodt
Julphar
Johnson and Johnson
Fish and Richardson
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.